A microscope.
(Image credit: Illustrated | iStock)

Tuesday's elections continue to make headlines, but the big news at the end of the week was the announcement of a new antiviral treatment for COVID-19. According to Pfizer, which developed the drug, Paxlovid cuts the risk of hospitalization or death by 89 percent. The drug doesn't prevent infection, so it's not exactly a cure. Combined with vaccines, though, it could reduce the pandemic from a social crisis to a seasonal annoyance.

That's not the only good news from the scientific world. On Friday, The New York Times reported a Russian project that provides heat using a small, sea-borne nuclear reactor. Although there are genuine risks, nuclear energy is the most plausible low-emissions alternative to fossil fuel. That means it's an unavoidable part of any serious response to climate change.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Samuel Goldman

Samuel Goldman is a national correspondent at TheWeek.com. He is also an associate professor of political science at George Washington University, where he is executive director of the John L. Loeb, Jr. Institute for Religious Freedom and director of the Politics & Values Program. He received his Ph.D. from Harvard and was a postdoctoral fellow in Religion, Ethics, & Politics at Princeton University. His books include God's Country: Christian Zionism in America (University of Pennsylvania Press, 2018) and After Nationalism (University of Pennsylvania Press, 2021). In addition to academic research, Goldman's writing has appeared in The New York Times, The Wall Street Journal, and many other publications.